Work

P115 A phase 2 multicenter study of the investigational single agent orteronel (ortl, TAK-700) in nonmetastatic castration-resistant prostate cancer (nmCRPC) and rising prostate-specific antigen (PSA)

Year: 2012

Type: conference-abstract

Source: European Urology Supplements

DOI: 10.1016/s1569-9056(13)60481-9

Authors: M. Hussain, P.G. Corn, D. Michaelson, H.J. Hammers, J.J. Alumkal, C.J. Ryan, J.Y. Bruce, S. Moran, S.Y. Lee, P. Mortimer, D.J. George

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2044700704

Cites:

Cited by: 1

Related to: 10